Walgreens, CVS, Rite Aid and Walmart are limiting the purchase of at-home COVID-19 tests due to high demand amid the spread of the omicron variant and the approaching holidays.
Drug Store News interviewed Brenda Lord, vice president of private brands and quality assurance at CVS Health, about the retailer’s private-label program.
CVS Health noted that advancement of health services and primary care capabilities will augment performance in foundational businesses while creating new opportunities in high-growth markets.